Jie Wu
- Immunology top 5%
- interferon and immune responses 15
- Immune Response and Inflammation 8
- Cancer Research top 5%
- Molecular Medicine top 5%
- Molecular Biology top 10%
- Inflammasome and immune disorders 11
- Nephrology top 10%
-
- Gastric Cancer Management and Outcomes 7
-
- Nanoplatforms for cancer theranostics 7
-
- Helicobacter pylori-related gastroenterology studies 6
-
- Neuropeptides and Animal Physiology 5
-
- Estrogen and related hormone effects 5
- Journals
- Cell Death and Disease (5 papers)Surgical Infections (3 papers)Clinica Chimica Acta (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jie Wu
113 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 150
- Immunology 661
- Cancer Research 339
- Molecular Medicine 86
- Molecular Biology 1.1k
- Nephrology 76
Countries citing papers authored by Jie Wu
This map shows the geographic impact of Jie Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Wu more than expected).
Fields of papers citing papers by Jie Wu
This network shows the impact of papers produced by Jie Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Wu. The network helps show where Jie Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jie Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 5 | |
| 3 | 2025 | 5 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 17 | |
| 7 | 2024 | 31 | |
| 8 | 2024 | 6 | |
| 9 | 2024 | 11 | |
| 10 | 2023 | 22 | |
| 11 | 2022 | 22 | |
| 12 | 2021 | 52 | |
| 13 | 2021 | 8 | |
| 14 | 2019 | 13 | |
| 15 | 2018 | 52 | |
| 16 | 2018 | 1 | |
| 17 | 2018 | 4 | |
| 18 | 2017 | 6 | |
| 19 | 2017 | 33 | |
| 20 | 17. Phase II study of oxaliplatin plus S-1 as neoadjuvant chemotherapy for advanced gastric cancer: Response and safety results | 2012 | 1 |
About Jie Wu
Jie Wu is a scholar working on Research and Theory, Immunology and Molecular Medicine, having authored 117 papers that have together received 2.5k indexed citations. Recurring topics across this work include interferon and immune responses (15 papers), Inflammasome and immune disorders (11 papers), Immune Response and Inflammation (8 papers), Gastric Cancer Management and Outcomes (7 papers), Nanoplatforms for cancer theranostics (7 papers), Helicobacter pylori-related gastroenterology studies (6 papers), Neuropeptides and Animal Physiology (5 papers) and Estrogen and related hormone effects (5 papers). The work is most often cited by research in Immunology (661 citations), Cancer Research (339 citations) and Molecular Medicine (86 citations). Jie Wu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiuwen Wu, Jianan Ren, Xufei Zhang, Qiongyuan Hu, Yun Zhao, Qinjie Liu, Gefei Wang, Zhiwu Hong, Huajian Ren and Guanwei Li. Their work appears in journals such as Cell Death and Disease, Surgical Infections, Clinica Chimica Acta, Frontiers in Immunology and Acta Biomaterialia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.